Recent Study: Cepheid Market Share Analysis

Fast Market Research recommends "Cepheid Market Share Analysis" from GlobalData, now available

by Bill Thompson

(WireNews+Co) - Boston, MA - 12 March 2013

GlobalData's new report, "Cepheid Market Share Analysis" provides in-depth information on Cepheid's market position in the different medical equipment markets it operates in. The report provides Cepheid market share information in two key market categories - Genetic Testing and Infectious Immunology. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Cepheid operates in - In Vitro Diagnostics.
- Cepheid's company shares (in Revenues) information for all the key country the company has presence in - United States.
- Cepheid's company shares (in Revenues) information for all the key market categories the company has presence in - Genetic Testing and Infectious Immunology.
- All the key data-points are for 2011 and cover all the key region - North America.
- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in..
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

View Full Report Details and Table of Contents (http://www.fastmr.com/prod/544267_cepheid_market_share_analysis.aspx?afid=201) (http://www.fastmr.com/prod/544267_cepheid_market_share_analysis.aspx?afid=201)

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Cepheid operates in.
- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Cepheid's market positions.

Companies Mentioned in this Report: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Qiagen N.V., Bio-Rad Laboratories, Inc., Gen-Probe Incorporated, Innogenetics NV, Nuclear Laser Medicine srl, bioMerieux S.A., Becton, Dickinson and Company, Alere Inc., DiaSorin S.p.A, Beckman Coulter, Inc., Hologic, Inc., Shanghai Kehua Bio-engineering Co., Ltd., PerkinElmer, Inc., OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Thermo Fisher Scientific Inc., Cellestis Limited, Trivitron Healthcare Pvt Ltd., Span Diagnostics Ltd., Tulip Diagnostics (P) Ltd, Genzyme Virotech GmbH, ELITech Group, Chembio Diagnostics, Inc.

Fast Market Research (http://www.fastmr.com?afid=201) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.